A carregar...
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD
Reduced GFR in patients with CKD causes systemic accumulation of uremic toxins, which has been correlated with disease progression and increased morbidity. The orally administered spherical carbon adsorbent AST-120 reduces systemic toxin absorption through gastrointestinal sequestration, which may s...
Na minha lista:
| Publicado no: | J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Nephrology
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4483576/ https://ncbi.nlm.nih.gov/pubmed/25349205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014010042 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|